Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Anterior Choroidal Artery Infarction

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Anterior Choroidal Artery Infarction in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marco, I1
Valhondo, M1
Martín-Fontecha, M1
Vázquez-Villa, H1
Del Río, J1
Planas, A1
Sagredo, O1
Ramos, JA1
Torrecillas, IR1
Pardo, L1
Frechilla, D1
Benhamú, B1
López-Rodríguez, ML1
Ramos, AJ1
Rubio, MD1
Defagot, C1
Hischberg, L1
Villar, MJ1
Brusco, A1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Anterior Choroidal Artery Infarction

ArticleYear
New serotonin 5-HT(1A) receptor agonists with neuroprotective effect against ischemic cell damage.
    Journal of medicinal chemistry, 2011, Dec-08, Volume: 54, Issue:23

    Topics: Amino Acid Sequence; Animals; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Cell Death; Cell

2011
The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
    Brain research, 2004, Dec-31, Volume: 1030, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Astrocytes; Brain Ischemia; Cell Death; Cerebral Co

2004